Cargando…
COVID-19 alters thinking and management in metabolic diseases
Metabolic diseases emerged as important risk factors for severe COVID-19, but the mechanisms responsible remained unclear for some time. The severity of metabolic diseases was also associated with worse outcomes in patients with COVID-19, forcing clinicians to adjust their thinking on which patients...
Autor principal: | le Roux, Carel W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687210/ https://www.ncbi.nlm.nih.gov/pubmed/33239662 http://dx.doi.org/10.1038/s41574-020-00449-y |
Ejemplares similares
-
Metabolic disorders, COVID-19 and vaccine-breakthrough infections
por: Stefan, Norbert
Publicado: (2021) -
The countries that tamed covid-19
por: Le Page, Michael
Publicado: (2020) -
COVID-19 and the neurological disease therapeutic pipeline
por: Jicha, Gregory A., et al.
Publicado: (2020) -
Rheumatic disease and COVID-19: epidemiology and outcomes
por: Hyrich, Kimme L., et al.
Publicado: (2020) -
COVID-19 vaccination in individuals with inflammatory rheumatic diseases
por: Skapenko, Alla, et al.
Publicado: (2022)